DECIPHERING THE GENETIC LANDSCAPE OF ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE BY TRANSCRIPTOME ANALYSIS USING RNA SEQUENCING

EHA Library, Frank Rücker, 215282

PHOSPHO-PROFILING LINKING AML-BIOLOGY AND RESPONSE PREDICTION IN PEDIATRIC MYELOID LEUKEMIA

EHA Library, Michaela Prchal-Murphy, 215283

TOWARDS IMPROVING OF SURVIVAL IN AML BY REPURPOSING EXISTING DRUGS AS NOVEL SAMHD1 INHIBITORS

EHA Library, Nikolaos Tsesmetzis, 215284

GENOMIC-DRIVEN AND FUNCTIONAL ALTERATIONS IN ENERGY, AMINO ACID AND LIPID METABOLISM IN ACUTE MYELOID LEUKEMIA BLASTS AND STEM PROGENITOR CELLS

EHA Library, Giorgia Simonetti, 215285

THE CALCIUM BINDING PROTEIN S100A8/S100A9 COMPLEX IS ASSOCIATED WITH DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Riikka Karjalainen, 215286

A HIGH RISK PEDIATRIC AML SUBTYPE PRESENTS A DIAGNOSTIC CHALLENGE-A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP AAML0531 STUDY

EHA Library, Timothy P Singleton, 215288

TARGETED COMBINATION THERAPY AGAINST ONCOGENIC PI3K/AKT/MTOR AND NFKB SIGNALLING PATHWAYS USING ACUTE MYELOID LEUKEMIA AS A CANCER MODEL

EHA Library, Montserrat Estruch Alrich, 215289

IDENTIFICATION OF GENE COPY NUMBER ABERRATIONS AS PROGNOSTIC MARKERS OF SURVIVAL IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS BY EXOME SEQUENCING OF LEUKEMIA DNA IN THE MAYO CLINIC AML EPIDEMIOLOGY COHORT

EHA Library, Yan Asmann, 215290

NEO2734, A NOVEL HIGHLY POTENT ORAL DUAL BET AND P300/CBP BROMODOMAIN INHIBITOR FOR TREATMENT OF HEMATOLGICAL MALIGNANCIES

EHA Library, Bill Brown, 215291

ACUTE MYELOID LEUKEMIA INDUCED TRANSFORMATION OF THE HUMAN BONE MARROW MICROENVIRONMENT PREDICTS CLINICAL OUTCOME

EHA Library, Yiyang Chen, 215292

IMMUNOPHENOTYPIC PROFILING OF LEUKEMIC STEM CELLS TO TRACK FLT3-ITD POSITIVE, CHEMO-RESISTANT CLONES IN ACUTE MYELOID LEUKEMIA

EHA Library, Tiziana Ottone, 215293

ASSESSMENT OF HIGH-RISK MOLECULAR MARKERS IN INTERMEDIATE RISK ACUTE MYELOID LEUKEMIA AS DEFINED BY 2010 ELN RISK CLASSIFICATION

EHA Library, Ekaterina Panina, 215294

MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)

EHA Library, Orietta Spinelli, 215295

SINGLE CELL SIGNALING PHARMACODYNAMICS AND CLONAL EVOLUTION IN A PHASE 1/2 CLINICAL TRIAL OF SELECTIVE AXL INHIBITOR BEMCENTINIB (BGB324) IN R/R ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Monica Hellesøy, 215296

FURTHER EVIDENCE FOR GPR56, BUT NOT CLL-1 (CLEC12A) AS A MARKER FOR LEUKEMIC STEM CELLS IN CD34-POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Albert Wölfler, 215297

MOLECULAR ABNORMALITIES IN THERAPY-RELATED ACUTE MYELOID LEUKEMIAS

EHA Library, Gueorgui Balatzenko, 215298

CD123 REDIRECTED NK92 CELLS FOR ACUTE MYELOID LEUKEMIA

EHA Library, Li Zhou, 215299

THE DIFFERENTIAL EXPRESSION OF DNMT3A SPLICE VARIANTS AND THEIR PROGNOSTIC RELEVANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Stefanie Beinicke, 215300

P53(D281G) MUTATION CAUSES CYTARABINE RESISTANCE VIA PROMOTING WARBURG EFFECT IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Kit Man Ng, 215301

EVALUATION OF THE DRUG INTERACTION POTENTIAL OF PRACINOSTAT, A NOVEL HISTONE DEACETYLASE (HDAC) INHIBITOR, WITH CYP1A2 INDUCER CIGARETTE SMOKING AND CIPROFLOXACIN, A CYP1A2 INHIBITOR

EHA Library, Alberto Bernareggi, 215302

SINGLE CENTRE REAL-LIFE EXPERIENCE OF HYPOMETHYLATING AGENTS WITH OR WITHOUT DLI AS SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Davide Lazzarotto, 215303

CONSOLIDATION CHEMOTHERAPY PREVENTS RELAPSE BY INDIRECTLY REGULATING BONE MARROW ADIPOGENESIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Hanyan Liu, 215304

CONTINUING ENASIDENIB TREATMENT FOR PATIENTS WITH MUTANT-IDH2 RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) WITH STABLE DISEASE MAY RESULT IN IMPROVED RESPONSES AND SURVIVAL OVER TIME

EHA Library, Eytan M. Stein, 215305

PH II TRIAL WITH SELECTIVE ORAL AXL INHIBITOR BEMCENTINIB (BGB324) IN RELAPSED/REFRACTORY AML AND MDS: IDENTIFICATION OF PREDICTIVE AND PHARMACODYNAMIC BIOMARKER CANDIDATES ASSOCIATED WITH PT BENEFIT

EHA Library, Julia Schoelermann, 215306

CYTOGENETIC AND MOLECULAR DRIVERS OF OUTCOME WITH VENETOCLAX-BASED COMBINATION THERAPIES IN TREATMENT-NAÏVE ELDERLY PATIENTS WITH AML

EHA Library, Stephen Strickland, 215307

RANDOMIZED OPEN-LABEL, PHASE III MULTICENTER TRIAL TO EVALUATE AZACITIDINE POST-REMISSION THERAPY IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Esther Oliva, 215308

A PHASE 2B OF ERYASPASE IN COMBINATION WITH LOW-DOSE CYTARABINE AS FIRST-LINE THERAPY IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (ENFORCE - NCT01810705)

EHA Library, X. Thomas, 215309

AN EVALUATION OF CONTROL REGIMENS IN A GROUP OF HIGH RISK OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA FROM TWO COOPERATIVE GROUPS: DATA FROM THE UK NCRI AND DUTCH HOVON STUDIES

EHA Library, Robert Hills, 215310

TP53 ALTERATIONS AND MONOSOMAL KARYOTYPE IN OLDER UNFIT PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH DECITABINE

EHA Library, Heiko Becker, 215311

IDENTIFYING A GENETICALLY DEFINED RISK GROUP OF PEDIATRIC AML PATIENTS THAT CANNOT BE RESCUED AT ALL AFTER THE FAILURE OF THE FIRST LINE TREATMENT

EHA Library, Naghmeh Niktoreh Mofrad, 215312

A PHASE II STUDY OF THE AURORA A KINASE INHIBITOR ALISERTIB COMBINED WITH 7+3 INDUCTION CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Amir Fathi, 215313

ADMINISTRATION OF BPX-501 CELLS FOLLOWING ALPHA/BETA T-CELL AND B-CELL-DEPLETED HLA HAPLOIDENTICAL HSCT (HAPLO-HSCT) IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Neena Kapoor, 215314

COMPARISON BETWEEN MULTIPARAMETRIC FLOW CYTOMETRY AND RT-QPCR ASSAY IN EVALUATING MINIMAL RESIDUAL DISEASE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IN NPM1 ACUTE MYELOID LEUKEMIA

EHA Library, Chiara Caprioli, 215315

MRD STATUS AT TRANSPLANTATION IN SECOND OR THIRD CR IS THE STRONGEST FACTOR AFFECTING THE PROBABILITY OF RELAPSE IN AML PATIENTS

EHA Library, Fabio Guolo, 215316

THE CXCR4 INHIBITOR BL-8040 IN COMBINATION WITH CYTARABINE RESULTS IN A SIGNIFICANTLY EXTENDED OVERALL SURVIVAL OF RELAPSED/REFRACTORY AML PATIENTS

EHA Library, Gautam Borthakur, 215317

CELL-FREE DNA MONITORING OF MINIMAL RESIDUAL DISEASE IN AML USING A TARGETED NGS GENE PANEL

EHA Library, Zhiyi Xie, 215318

INTRA-PATIENT DOSE-ESCALATION STUDY OF CRENOLANIB MAINTENANCE THERAPY IN PATIENTS WITH FLT3 MUTANT AML WHO HAD UNDERGONE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)

EHA Library, Betul Oran, 215319

CONSOLIDATION THERAPY WITH PONATINIB IN COMBINATION WITH CYTARABINE IN PATIENTS FOR FLT3-ITD ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION.

EHA Library, Philippe Rousselot, 215320

PHASE 1/1B STUDY OF PEVONEDISTAT (PEV) AS A SINGLE AGENT OR COMBINED WITH AZACITIDINE (AZA) IN EAST ASIAN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, SHANG-JU WU, 215321

ANALYSIS OF PHASE I AND PILOT PHASE II DATA REVEAL 2,000 MG/M2 AS THE OPTIMAL DOSE OF CPI-613 IN COMBINATION WITH CYTARABINE AND MITOXANTRONE FOR ELDERLY PATIENTS WITH RELAPSED OR REFRACTORY AML

EHA Library, Timothy Pardee, 215322

CLADRIBINE ADDED TO STANDARD INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKAEMIA, 4-YEAR EXPERIENCES FROM SLOVENIA

EHA Library, Saša Anžej Doma, 215323

DECITABINE AS SINGLE AGENT FOR TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS: A RETROSPECTIVE, MULTICENTER REAL LIFE STUDY OF THE “RETE EMATOLOGICA PUGLIESE” (REP)

EHA Library, Maria Pia Loglisci, 215324

FLUDARABINE, HIGH DOSE CYTARABINE AND IDARUBICIN-BASED INDUCTION (FLAI) IS HIGHLY EFFECTIVE IN AML WITH MUTATED NPM1 WITH CONCOMITANT FLT3-ITD MUTATION IRRESPECTIVELY OF FLT3-ITD ALLELIC BURDEN

EHA Library, Paola Minetto, 215325

CLINICAL CHARACTERISTICS AND PROGNOSIS OF 34 CASES OF ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION AND MLL GENE REARRANGEMENT

EHA Library, Jian Ouyang, 215326

PROGNOSTIC RELEVANCE OF FLT3, NPM1, DNMT3A, IDH1/2 GENE MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Irina Martynkevich, 215327

IMPACT OF BCL2 AND ABCG2 OVEREXPRESSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Mario Tiribelli, 215328

ABSOLUTE LYMPHOCYTE COUNT RECOVERY AFTER INDUCTION REMISSION THERAPY IS A STRONG PREDICTOR OF OVERALL SURVIVAL IN ADULT ACUTE MYELOID LEUKAEMIA

EHA Library, Joana Infante, 215329

TYROSINE KINASE INHIBITORS (TKI) IN RELAPSED/REFRACTORY (RR) PATIENTS WITH FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA (AML) CONFER BETTER SURVIVAL THAN CHEMOTHERAPY, DUE TO A BETTER SAFETY PROFILE.

EHA Library, Giovanni Marconi, 215330

ADDITION OF BORTEZOMIB TO AML-LIKE TREATMENT FOLLOWED BY NMA ALLO-SCT IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Elisabeth Tolley, 215331

BLAST TRANSFORMATION IN MYELODYSPLASTIC AND MYELOPROLIFERATIVE NEOPLASMS - SIMILARITIES AND DIFFERENCES - A REVIEW OF 100 CASES

EHA Library, Milan Jagurinoski, 215332

QUALITY OF LIFE IN ACUTE LEUKEMIA PATIENTS WITH COMORBID ISCHEMIC HEART DISEASE

EHA Library, Tetiana Lymanets, 215333

BIOMARKER ANALYSIS OF TISAGENLECLEUCEL PRE-INFUSION BIOPSIES OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Ulrich Jäger, 215334

ACALABRUTINIB IN COMBINATION WITH THE PI3Kδ INHIBITOR ACP-319 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES.

EHA Library, Paul M. Barr, 215335

TIME TO RELAPSE OF MANTLE CELL LYMPHOMA AFTER INTENSIVE HIGH DOSE CYTARABINE CONTAINING REGIMENS DEFINES PATIENTS RISK FOR DEATH: AN ANALYSIS FROM CENTERS OF THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Carlo Visco, 215336

CC-122-DLBCL-001: PHASE IB STUDY OF CC-122 PLUS RITUXIMAB IN PATIENTS WITH CHEMO-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Vincent Ribrag, 215337

EXTRACELLULAR CIRCULATING DNA IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: BIOLOGICAL CORRELATES AND PROGNOSTIC IMPACT

EHA Library, Dino Dujmovic, 215338

ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE PHASE 1B ACE-LY-002 STUDY

EHA Library, Martin J. S. Dyer, 215339

OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)

EHA Library, Robert Pytlik, 215340

WOMEN WITH DIFFUSE LARGE B CELL LYMPHOMA BENEFIT MORE FROM RITUXIMAB-CONTAINING CHEMOTHERAPY

EHA Library, Huai-Hsuan Huang, 215341

RITUXIMAB, BENDAMUSTINE AND CYTARABINE (R-BAC) IN PATIENTS WITH RELAPSED-REFRACTORY AGGRESSIVE B- CELL LYMPHOMA

EHA Library, Maria Chiara Tisi, 215342

A PROPENSITY SCORE ANALYSIS SHOWS THAT RITUXIMAB DOSE-ADJUSTED EPOCH IMPROVES PROGRESSION-FREE SURVIVAL OF YOUNG PATIENTS AFFECTED BY DOUBLE EXPRESSOR DIFFUSE LARGE B -CELL LYMPHOMAS

EHA Library, Anna Guidetti, 215343

GENETIC EVIDENCE IMPLYING THE COMMON PRECURSOR CELLS FOR PRIMARY AND EXTRA-CENTRAL NERVOUS SYSTEM RELAPSED TUMORS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Keiichiro Hattori, 215344

REAL-TIME CELL-OF-ORIGIN SUBTYPE IDENTIFICATION BY GENE EXPRESSION PROFILING IN PATIENTS WITH ABC-TYPE DLBCL IN THE PHASE III TRIAL OF LENALIDOMIDE + R-CHOP (R2-CHOP) VS PLACEBO + R-CHOP (ROBUST)

EHA Library, Annalisa Chiappella, 215345

EXCELLENT OUTCOMES OF OLDER PATIENTS WITH PCNSL USING R-MPV/ARA-C IMMUNOCHEMOTHERAPY WITHOUT WHOLE BRAIN RADIOTHERAPY (WBRT)

EHA Library, Gareth Gregory, 215346

FIRST REPORT ON A SUCCESSFUL SCREENING PROGRAM FOR MYC REARRANGEMENTS AND A PROSPECTIVE CLINICAL TRIAL BASED ON MYC REARRANGEMENT IN NEWLY DIAGNOSED DLBCL PATIENTS IN THE NETHERLANDS

EHA Library, Martine Chamuleau, 215347

A NOVEL IMMUNOHISTOCHEMICAL PROGNOSTIC SCORE BASED ON MYC, BCL2 AND BCL6 EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RETROSPECTIVE ANALYSIS OF DE NOVO DLBCL TREATED WITH RITUXIMAB-CHOP

EHA Library, Mattia Novo, 215348

ASSESSMENT OF BONE MARROW INFILTRATION AND MINIMAL RESIDUAL DISEASE BY MULTIDIMENSIONAL FLOW CYTOMETRY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, M Baile, 215349

ON THE APPLICABILITY OF RHOA GLY17VAL POINT MUTATION TESTING FOR A DIFFERENTIAL DIAGNOSIS OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Yulia Sidorova, 215350

THE ADDITION OF ROMIDEPSIN TO CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IS FEASIBLE IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS: RESULTS OF PHASE IB FIL-PTCL13

EHA Library, Annalisa Chiappella, 215351

A PHASE I, MULTICENTER, OPEN-LABEL DOSE-ESCALATION STUDY OF CC-122, A NOVEL CEREBLON-MODULATING AGENT, IN ADULT JAPANESE PATIENTS WITH ADVANCED NON-HODGKIN LYMPHOMA OR SOLID TUMOR

EHA Library, Kazuhito Yamamoto, 215352

GLOBAL LONGITUDINAL STRAIN (2D-GLS) IN LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY +/- MEDIASTINAL RADIOTHERAPY: EARLY SUBCLINICAL CARDIOTOXICITY IN THE CARDIOCARE PROSPECTIVE OBSERVATIONAL STUDY.

EHA Library, Barbara Botto, 215353

CLINICAL FEATURES, TREATMENT AND PROGNOSTIC FACTORS FOR EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA, NASAL TYPE, IN THE SPANISH POPULATION. A STUDY FROM THE SPANISH GROUP GELTAMO.

EHA Library, EVA GONZALEZ BARCA, 215354

ARE OUTCOMES IMPROVING IN POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER? A RETROSPECTIVE ANALYSIS OF THE LAST 10 YEARS

EHA Library, Nicholas Denny, 215355

PHASE II STUDY WITH OBINUTUZUMAB-DHAP IN RELAPSED/REFRACTORY DLBCL PATIENTS BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (GIOTTO STUDY)

EHA Library, Luigi Rigacci, 215356

COMPARISON OF R-CHOP, R-CVP, CHOP, AND CVP FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN TAIWAN: A POPULATION-BASED STUDY, 2009-2013

EHA Library, Huai-Hsuan Huang, 215357

HIGH INCIDENCE OF CARDIOMYOPATHY IN PATIENTS RECEIVING CHOEP14 - POSSIBLE SYNERGISTIC CARDIOTOXICITY OF DOSE-DENSE DOXORUBICIN AND ETOPOSIDE

EHA Library, Igor Aurer, 215358

PROGNOSTIC IMPACT OF SITES OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA

EHA Library, Norihito Inoue, 215359

LIPOSOMAL DOXORUBICIN IN AGGRESSIVE B CELL LYMPHOMA SHOWS SIMILAR EFFICACY TO THE CONVENTIONAL FORMULATION: LONG TERM RESULTS FROM A RETROSPECTIVE COHORT STUDY

EHA Library, Ana García-Noblejas, 215360

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF HEMOPHAGOCYTIC SYNDROME IN ADULT PATIENTS: A RETROSPECTIVE SINGLE-CENTER STUDY FROM SINGAPORE

EHA Library, Shin-Yeu ONG, 215361

THE IMPACT OF DIFFERENT IMMUNOCHEMOTHERAPY REGIMENS ON SURVIVAL OUTCOMES IN 131 NEWLY DIAGNOSED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Gayane Tumyan, 215362

TREATMENT OF TRAUMATIC BLEEDS WITH RECOMBINANT FACTOR XIII-A2 IN PATIENTS WITH CONGENITAL FXIII-A SUBUNIT DEFICIENCY: RESULTS FROM THE MENTOR™6 STUDY

EHA Library, Jolanta Klovaite, 215363

BEVACIZUMAB SIGNIFICANTLY IMPROVES SEVERE EPISTAXIS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA

EHA Library, Silva Zupancic salek, 215364

AN AUDIT OF THE USE OF PROTHROMBIN COMPLEX CONCENTRATION

EHA Library, Samantha Bonney, 215365

HAEMOSTATIC ABNORMALITIES OR DEFECTS IN GREEK PATIENTS WITH GAUCHER DISEASE

EHA Library, Veroniki Komninaka, 215366

THALIDOMIDE USE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: A RETROSPECTIVE EVALUATION OF THE PATIENTS

EHA Library, Mehmet Baysal, 215367

DIAGNOSIS AND MANAGEMENT OF ACQUIRED VON WILLEBRAND DISEASE. A SINGLE CENTER EXPERIENCE

EHA Library, Cristina Santoro, 215368

CONGENITAL FXIII DEFICIENCY IN PAKISTAN

EHA Library, Munira Borhany, 215369

DISSEMINATED INTRAVASCULAR COAGULATION SCORING IN CHILDREN WITH ACUTE LEUKEMIA: IS THERE A SIMPLER AND ECONOMICAL ALTERNATIVE?

EHA Library, Yasmine El Chazli, 215370

EFFECT OF THROMBOELASTOGRAPHY DEFINED COAGULOPATHY IN TRAUMATIC BRAIN INJURY

EHA Library, DIBYENDU DE, 215371

ASSESSMENT AT DIAGNOSIS OF 200 PATIENTS WITH A PNH CLONE OR GPI-DEFICIENT CELLS ≥0.01% ENROLLED IN A NATION-WIDE MULTICENTRIC PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Orianne Wagner-Ballon, 215372

ASSOCIATION OF AUTOPHAGY-RELATED GENE 5 VARIANTS WITH ACQUIRED APLASTIC ANEMIA IN HAN-CHINESE POPULATION

EHA Library, Yahong You, 215373

PHASE IB STUDY OF THE CXCR4 ANTAGONIST BL8040 COMBINED WITH IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH APLASTIC ANEMIA

EHA Library, Tapan Kadia, 215374

CLINICAL EFFICACY OF THERAPIES FOR TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A RETROSPECTIVE COHORT STUDY IN MULTIPLE HOSPITALS

EHA Library, Guangsheng He, 215375

IDIOPATHIC NEUTROPENIA OF INFANCY: DATA FROM THE ITALIAN NEUTROPENIA REGISTRY

EHA Library, Piero Farruggia, 215376

DYNAMICS OF CMV AND EBV LOADS AFTER IMMUNOSUPPRESSIVE TREATMENT WITH RABBIT ATG AND CYCLOSPORINE IN ADULT APLASTIC ANEMIA: A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Jong Wook Lee, 215377

PHASE 2 STUDY OF X4P-001: A TARGETED ORAL THERAPY FOR PATIENTS WITH WHIM SYNDROME

EHA Library, David Dale, 215378

SCREENING FOR TELOMERE DISEASE IS IMPORTANT TO IMPROVE THE OUTCOME OF HSCT IN PEDIATRIC PATIENTS SUFFERING FROM SEVERE APLASTIC ANEMIA.

EHA Library, Iris Nederlof, 215379

RESULTS OF HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN CONGENITAL BONE MARROW FAILURE SYNDROMES: SINGLE CENTER EXPERIENCE WITH FOCUS ON TCR ΑΒ+/CD19+ DEPLETION

EHA Library, Zhanna Shekhovtsova, 215380

REACTIVATION OF HEPATITIS B VIRUS INFECTION IN APLASTIC ANEMIA PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY

EHA Library, Guangsheng He, 215381

ADULT PATIENTS WITH ACQUIRED PURE RED CELL APLASIA: COMBINATION OF CYCLOSPORINE A AND CORTICOSTEROIDS PRODUCE BETTER CR

EHA Library, Guangsheng He, 215382